Jounce Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2016 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Jounce Therapeutics, Inc. annual/quarterly Depreciation history and growth rate from Q1 2016 to Q1 2022.
  • Jounce Therapeutics, Inc. Depreciation for the quarter ending March 31, 2022 was $590K, a 24.8% decline year-over-year.
  • Jounce Therapeutics, Inc. annual Depreciation for 2022 was $2.09M, a 26.2% decline from 2021.
  • Jounce Therapeutics, Inc. annual Depreciation for 2021 was $2.83M, a 16.9% decline from 2020.
  • Jounce Therapeutics, Inc. annual Depreciation for 2020 was $3.4M, a 11.7% decline from 2019.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $590K -$195K -24.8% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q1 2021 $785K -$153K -16.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $938K -$22K -2.29% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q1 2019 $960K +$13K +1.37% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 $947K -$19K -1.97% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 $966K +$519K +116% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q1 2016 $447K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.